Cash on Hand for Bio-Techne (TECH)
According to Bio-Techne's latest reported financial statements, the company's latest reported cash and short-term investments is $172.88M USD. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for a net cash/debt picture and with total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
TECH
Currently viewingCash on HandSwitch metric
Latest period
$172.88M
YoY change
+6.1%
5Y CAGR
-9.8%
Peak year (2014)
$363.35M
Latest annual
$162.19M
Cash on Hand history chart for Bio-Techne (TECH) from 1989 to 2025
Cash on Hand history table for Bio-Techne (TECH) from 1989 to 2025
| Fiscal year | Period ended | Reported | Cash on Hand | YoY |
|---|---|---|---|---|
| 2025 | $162.19M | +6.1% | ||
| 2024 | $152.86M | -25.2% | ||
| 2023 | $204.31M | -17.3% | ||
| 2022 | $247.03M | +6.7% | ||
| 2021 | $231.55M | -14.5% | ||
| 2020 | $270.89M | +63.2% | ||
| 2019 | $166.03M | -8.6% | ||
| 2018 | $181.75M | +15.2% | ||
| 2017 | $157.71M | +64.6% | ||
| 2016 | $95.83M | -13.6% | ||
| 2015 | $110.92M | -69.5% | ||
| 2014 | $363.35M | +9.1% | ||
| 2013 | $332.94M | +23.8% | ||
| 2012 | $268.99M | +91.0% | ||
| 2011 | $140.81M | +1.4% | ||
| 2010 | $138.81M | -31.6% | ||
| 2009 | $202.89M | -1.7% | ||
| 2008 | $206.34M | +25.2% | ||
| 2007 | $164.77M | +51.4% | ||
| 2006 | $108.85M | +12.1% | ||
| 2005 | $97.13M | -45.0% | ||
| 2004 | $176.59M | +50.3% | ||
| 2003 | $117.50M | +21.1% | ||
| 2002 | $97.06M | -0.0% | ||
| 2001 | $97.07M | +62.3% | ||
| 2000 | $59.82M | +105.6% | ||
| 1999 | $29.10M | +6.2% | ||
| 1998 | $27.40M | +218.6% | ||
| 1997 | $8.60M | +16.2% | ||
| 1996 | $7.40M | +39.6% | ||
| 1995 | $5.30M | -10.2% | ||
| 1994 | $5.90M | +47.5% | ||
| 1993 | $4.00M | -11.1% | ||
| 1992 | $4.50M | +125.0% | ||
| 1991 | $2.00M | +53.8% | ||
| 1990 | $1.30M | +30.0% | ||
| 1989 | $1.00M | — |
Cash on Hand values are taken from Bio-Techne's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Bio-Techne (TECH) reported cash and short-term investments of $162.19M – grew 6.1% year-over-year.
Across 2020–2025 (5 years), Bio-Techne cash and short-term investments produced a CAGR of -9.8% – with a net decline across the window.
Between 2014 and 2025, Bio-Techne cash and short-term investments plunged 55.4%, falling from $363.35M to $162.19M.
The highest annual cash and short-term investments of $363.35M was reported in 2014. The lowest in the available history was $1.00M in 1989.
Within Healthcare, Bio-Techne (TECH) ranks 9th among 8 peers we track. The peer median for cash and short-term investments is $11.85B.
Bio-Techne Cash on Hand by Year
Bio-Techne Cash on Hand 2025: $162.19M
Bio-Techne cash and short-term investments in 2025 was $162.19M, grew 6.1% from 2024.
Bio-Techne Cash on Hand 2024: $152.86M
Bio-Techne cash and short-term investments in 2024 was $152.86M, declined 25.2% below 2023.
Bio-Techne Cash on Hand 2023: $204.31M
Bio-Techne cash and short-term investments in 2023 was $204.31M, declined 17.3% below 2022.
Bio-Techne Cash on Hand 2022: $247.03M
Bio-Techne cash and short-term investments in 2022 was $247.03M, grew 6.7% from 2021.
Bio-Techne Cash on Hand 2021: $231.55M
Bio-Techne cash and short-term investments in 2021 was $231.55M.
See more financial history for Bio-Techne (TECH).
Sector peers — Cash on Hand
Companies in the same sector as Bio-Techne, ranked by their latest cash and short-term investments.
| Company | Cash on Hand | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $28.12B | Healthcare |
| Novo Nordisk A/S (NVO) | $26.96B | Healthcare |
| Johnson & Johnson (JNJ) | $20.10B | Healthcare |
| Merck & Co., Inc. (MRK) | $14.56B | Healthcare |
| Amgen Inc. (AMGN) | $9.13B | Healthcare |
| Eli Lilly and Company (LLY) | $7.27B | Healthcare |
| AstraZeneca PLC (AZN) | $5.74B | Healthcare |
| AbbVie Inc. (ABBV) | $5.26B | Healthcare |
Frequently asked questions
What is Bio-Techne's cash and short-term investments?
- Latest reported cash and short-term investments for Bio-Techne (TECH) is $172.88M (period ending December 31, 2025).
How has Bio-Techne cash and short-term investments changed year-over-year?
- Bio-Techne (TECH) cash and short-term investments changed +6.1% year-over-year on the latest annual filing.
What is the long-term growth rate of Bio-Techne cash and short-term investments?
- Bio-Techne (TECH) cash and short-term investments compound annual growth rate is -9.8% over the most recent 5 years available.
When did Bio-Techne cash and short-term investments hit its highest annual value?
- Bio-Techne cash and short-term investments reached its highest annual value of $363.35M in 2014.
What was Bio-Techne cash and short-term investments in 2024?
- Bio-Techne (TECH) cash and short-term investments in 2024 was $152.86M.
What was Bio-Techne cash and short-term investments in 2025?
- Bio-Techne (TECH) cash and short-term investments in 2025 was $162.19M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
TECH Overview
Company profile, financial tools, and key metrics
TECH Revenue Counter
Earns $38.55 every second. See per minute, hour, and day.
TECH Earnings Counter
Earns $2.57 per second net profit. See per minute, hour, and day.
TECH Economic Scale
Exceeds Samoa's GDP. Compare with world economies.
TECH What If Invested
What if you had invested $1,000? See historical returns from any date.
TECH How It Makes Money
Discover visual breakdown of $1.22B in revenue — where it comes from and where it goes.
TECH Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
TECH Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
TECH Daily Price Character
Balanced · 45.3% historical win rate (green days). Streaks & record days.
TECH Buybacks
2.18% TTM buyback yield. Shareholder yield & SBC comparison.
TECH Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.
TECH Dividend Profile
Yield: 0.62%. Safety: 5/8. See full history.
TECH Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
TECH Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.